• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Dyslipidemia

Dyslipidemia

9780199742868
287,75 zł
258,97 zł Zniżka 28,78 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 258,97 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Dyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardialinfarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control.As part of the Oxford American Cardiology Library, this practical handbook is designed to serve as a concise yet authoritative resource on diagnosing and treating dyslipidemia. The book is tailored to the needs of busy health care professionals treating patients in various clinical settings, and focuses on presenting essential information to clinicians who are at the forefront of the diagnosis and management of dyslipidemia. Featuring evidence-based, concise yet comprehensivediscussion of key clinical concepts in addition to numerous figures, tables and illustrations, this pocket-sized handbook will serve as an invaluable guide to healthcare professionals.
Szczegóły produktu
OUP USA
86799
9780199742868
9780199742868

Opis

Rok wydania
2011
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
152
Wymiary (mm)
203 x 127
Waga (g)
187
  • Contributors; 1. LDL Cholesterol; 2. HDL Cholesterol; 3. Non-HDL Cholesterol; 4. Use of High Sensitivity C-reactive Protein for Risk Assessment; 5. Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6. Stratification of Dyslipidemic Risk; 7. Drugs for Treatment of Blood Lipoprotein Abnormalities; Index;
Komentarze (0)